Land: Malaysia
Språk: engelsk
Kilde: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
HEPARIN GLYCOSAMINOGLYCAN/NADROPARIN CALCIUM
Aspen Medical Products Malaysia Sdn Bhd
HEPARIN GLYCOSAMINOGLYCAN/NADROPARIN CALCIUM
2Units Units; 10Units Units
Aspen Notre Dame De Bondeville
Not Applicable Les hele dokumentet
1 FRAXIPARINE Nadroparin Calcium QUALITATIVE AND QUANTITATIVE COMPOSITION Pre-filled syringes: - 0.2 ml of solution equivalent to 1,900 anti-Xa IU - 0.3 ml of solution equivalent to 2,850 anti-Xa IU - 0.4 ml of solution equivalent to 3,800 anti-Xa IU Graduated pre-filled syringes: - 0.6 ml of solution equivalent to 5,700 anti-Xa IU - 0.8 ml of solution equivalent to 7,600 anti-Xa IU - 1 ml of solution equivalent to 9,500 anti-Xa IU PHARMACEUTICAL FORM Clear to slightly opalescent, colourless or slightly coloured solution for injection. CLINICAL INFORMATION Therapeutic Indications Prophylaxis of thromboembolic disorders, such as: • those associated with general or orthopaedic surgery • those in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure), immobilised due to acute illness or hospitalised in an intensive care unit Treatment of thromboembolic disorders Treatment of unstable angina and non-Q wave myocardial infarction Prevention of clotting during haemodialysis Posology and Method of Administration General Particular attention should be paid to the specific dosing instructions for each proprietary Low Molecular Weight Heparin, as different units of measurement (units or mg) are used to express doses. Nadroparin should therefore not be used interchangeably with other low molecular weight heparins during ongoing treatment. In addition, care should be taken to use the correct formulation of nadroparin, either single or double strength, as this will affect the dosing regimen. Graduated syringes are intended for use when dose adjustment for body weight is necessary. 2 Platelet count must be monitored throughout nadroparin treatment (see Special warnings and precautions for use). Specific recommendations regarding the timing of nadroparin dosing surrounding spinal/epidural anaesthesia or spinal lumbar puncture should be followed (see Special warnings and precautions for use). Posology Adults PROPHYLAXIS OF THROMBOEMBOLIC DISORDERS General Surge Les hele dokumentet